Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 43% ± 18% | |
| astrocyte | 13 studies | 63% ± 29% | |
| glutamatergic neuron | 12 studies | 83% ± 20% | |
| oligodendrocyte precursor cell | 12 studies | 78% ± 25% | |
| GABAergic neuron | 10 studies | 81% ± 19% | |
| microglial cell | 7 studies | 39% ± 20% | |
| retinal ganglion cell | 6 studies | 78% ± 28% | |
| vein endothelial cell | 6 studies | 39% ± 22% | |
| endothelial cell of lymphatic vessel | 6 studies | 37% ± 8% | |
| neuron | 5 studies | 55% ± 24% | |
| amacrine cell | 5 studies | 81% ± 27% | |
| retina horizontal cell | 5 studies | 77% ± 31% | |
| oligodendrocyte | 5 studies | 48% ± 23% | |
| type II pneumocyte | 5 studies | 29% ± 10% | |
| smooth muscle cell | 4 studies | 23% ± 6% | |
| fibroblast | 4 studies | 37% ± 14% | |
| mesothelial cell | 4 studies | 58% ± 19% | |
| Mueller cell | 4 studies | 33% ± 16% | |
| interneuron | 4 studies | 89% ± 14% | |
| GABAergic amacrine cell | 3 studies | 90% ± 7% | |
| OFF-bipolar cell | 3 studies | 68% ± 23% | |
| glycinergic amacrine cell | 3 studies | 92% ± 4% | |
| endothelial cell of vascular tree | 3 studies | 25% ± 2% | |
| granule cell | 3 studies | 79% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1692.30 | 2639 / 2642 | 92% | 14.32 | 649 / 705 |
| prostate | 60% | 190.23 | 148 / 245 | 50% | 1.65 | 252 / 502 |
| adrenal gland | 13% | 45.56 | 33 / 258 | 73% | 14.61 | 169 / 230 |
| breast | 29% | 60.87 | 132 / 459 | 41% | 1.87 | 463 / 1118 |
| pancreas | 3% | 5.11 | 9 / 328 | 66% | 1.88 | 117 / 178 |
| bladder | 48% | 231.81 | 10 / 21 | 10% | 0.36 | 52 / 504 |
| lung | 23% | 48.47 | 132 / 578 | 24% | 0.71 | 273 / 1155 |
| adipose | 41% | 108.92 | 494 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 21% | 59.40 | 37 / 180 | 20% | 0.36 | 88 / 430 |
| thymus | 13% | 27.28 | 83 / 653 | 27% | 0.83 | 161 / 605 |
| kidney | 11% | 24.67 | 10 / 89 | 23% | 0.71 | 205 / 901 |
| intestine | 15% | 30.00 | 141 / 966 | 17% | 0.61 | 91 / 527 |
| esophagus | 9% | 21.14 | 128 / 1445 | 21% | 0.67 | 39 / 183 |
| uterus | 16% | 44.94 | 28 / 170 | 13% | 0.47 | 60 / 459 |
| blood vessel | 27% | 62.15 | 357 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 4% | 7.99 | 15 / 359 | 22% | 0.59 | 63 / 286 |
| skin | 5% | 11.01 | 87 / 1809 | 5% | 0.35 | 25 / 472 |
| liver | 0% | 0 | 0 / 226 | 7% | 0.26 | 29 / 406 |
| heart | 4% | 5.97 | 32 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.05 | 2 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
| spleen | 0% | 0.73 | 1 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0098703 | Biological process | calcium ion import across plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0015275 | Molecular function | stretch-activated, monoatomic cation-selective, calcium channel activity |
| Gene name | NALF1 |
| Protein name | NALCN channel auxiliary factor 1 (Transmembrane protein FAM155A) |
| Synonyms | NLF-1 FAM155A |
| Description | FUNCTION: Auxillary component of the NALCN sodium channel complex, a channel that regulates the resting membrane potential and controls neuronal excitability. . |
| Accessions | ENST00000375915.4 B1AL88 |